Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing (Q58797082)

18

Heli Nevanlinna

0 references

Fergus J. Couch

29

Fergus J Couch

0 references

Peter A. Fasching

13

Peter A Fasching

0 references

Hiltrud Brauch

9

Hiltrud Brauch

0 references

Drakoulis Yannoukakos

20

Drakoulis Yannoukakos

0 references

Florentia Fostira

14

Florentia Fostira

0 references

Angela Cox

10

Angela Cox

0 references

Judy E. Garber

15

Judy Garber

0 references

David Goldgar

26

David E Goldgar

0 references

Irene Konstantopoulou

17

Irene Konstantopoulou

0 references

author name string

Hermela Shimelis

1

0 references

Holly LaDuca

2

0 references

Chunling Hu

3

0 references

Steven N Hart

4

0 references

Jie Na

5

0 references

Abigail Thomas

6

0 references

Margaret Akinhanmi

7

0 references

Raymond M Moore

8

0 references

Amanda Ewart-Toland

12

0 references

Andrew K Godwin

16

0 references

Priyanka Sharma

19

0 references

Song Yao

21

0 references

Bing-Jian Feng

22

0 references

Brigette Tippin Davis

23

0 references

Jenna Lilyquist

24

0 references

Tina Pesaran

25

0 references

Eric C Polley

27

0 references

Jill S Dolinsky

Journal of the National Cancer Institute

28

0 references

language of work or name

English

0 references

publication date

7 August 2018

0 references

published in

0 references

volume

110

0 references

issue

8

0 references

page(s)

855-862

0 references

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

start time

7 August 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Analysis of protein-coding genetic variation in 60,706 humans

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Inherited Mutations in Women With Ovarian Carcinoma

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Triple-Negative versus Non-Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Gene-panel sequencing and the prediction of breast-cancer risk

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Breast-cancer risk in families with mutations in PALB2

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Triple-negative breast cancer: epidemiological considerations and recommendations

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Germline RAD51C mutations confer susceptibility to ovarian cancer

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Germline mutations in RAD51D confer susceptibility to ovarian cancer

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350

The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6093350